Related Experiment Videos
HBs Ag and hepatocellular carcinoma associated with cirrhosis.--A retrospective study based on autopsy
Insights
Hepatocellular carcinoma (HCC) associated with cirrhosis shows a more rapid and severe course when Hepatitis B surface antigen (HBs Ag) is present in liver cells. This suggests HBs Ag plays a role in HCC progression.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern, often developing in patients with liver cirrhosis.
- The role of Hepatitis B virus infection, specifically Hepatitis B surface antigen (HBs Ag), in HCC pathogenesis and progression requires further elucidation.
Purpose of the Study:
- To investigate the presence of HBs Ag in liver tissue of patients with HCC and cirrhosis.
- To determine if HBs Ag presence correlates with clinical outcomes and survival rates in HCC patients.
Main Methods:
- Histologic examination of liver tissue from 33 HCC patients with cirrhosis.
- Staining with hematoxylin-eosin and orcein to detect HBs Ag in hepatocytes.
- Review of clinical data and laboratory examinations to assess patient survival.
Main Results:
- HBs Ag was detected in the cytoplasm of liver cells in 7 out of 33 (21.2%) HCC patients.
- A significant difference in survival length was observed between HBs Ag-positive and HBs Ag-negative patients.
- HBs Ag-positive patients exhibited a more rapid and severe disease course.
Conclusions:
- HBs Ag presence in liver cells is associated with a poorer prognosis in HCC patients with cirrhosis.
- These findings support the hypothesis that HBs Ag contributes to both the development and accelerated progression of HCC.
- Further research into targeted therapies against HBs Ag in HCC is warranted.
Abstract:
Histologic specimens of liver tissue from 33 consecutive cases of hepatocellular carcinoma (HCC) associated with cirrhosis, were stained with hematoxylin-eosin and with orcein for the presence of HBs Ag in the cytoplasm of cells. Such a study showed orcein-positive liver cells in 7 out of 33 (21.2%) cases of HCC associated with cirrhosis. The clinical course and laboratory examinations of the 33 patients were also reviewed and revealed a significant difference between the length of survival of orcein-positive patients and orcein-negative ones. Therefore, these results seem to support the hypothesis that HBs Ag may play a role not only in the development of HCC associated with cirrhosis, but also in a more rapid and severe course of neoplasia.